Heart attack MRI registry aims to predict future risks
NCT ID NCT07291999
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is collecting information from 500 people who had a first heart attack and received a cardiac MRI. The goal is to see if MRI images of the heart can help predict who will have future heart problems like heart failure or need a heart transplant. Researchers are looking at heart tissue damage, blood flow, and other features to improve risk prediction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict which heart attack patients are at risk for future heart failure or other serious events.
- What could go wrong
- This is an observational registry, not a treatment trial. It may not lead to direct changes in patient care, and results may not apply to all heart attack patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
500 people
The number who actually took part.
- Started
-
Jan 2025
- Expected to finish
-
Dec 2036
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of patients admitted with a first ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI) and were evaluated by cardiac magnetic resonance (CMR) both in the acute phase and during follow-up. The study is conducted in tertiary academic hospitals with well-established CMR programs, ensuring standardized imaging protocols and high-quality data acquisition. Participating centers include the Hospital Clínic de Barcelona, the Hospital Clínico Universitario de Valencia, and the Hospital Universitari Vall d'Hebron, all located in Spain.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * First STEMI evaluated within the first 24 hours of symptom onset * At least one CMR performed during the acute phase * Signed informed consent (for prospective patients) or previous consent (for retrospective inclusion). Exclusion Criteria: * Severe renal failure (GFR \< 30 ml/min) * STEMI \> 24 hours after symptom onset * Contraindications to CMR (e.g., claustrophobia, hemodynamic instability, non-MR-compatible devices, vascular clips) * Pregnancy or breastfeeding.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ischemic cardiovascular disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico de Valencia
Valencia, 46010, Spain
-
Hospital Vall d'Hebron de Barcelona
Barcelona, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.